Largazole: From discovery to broad-spectrum therapy
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The cyclic depsipeptide largazole from a cyanobacterium of the genus Symploca is a marine natural product with a novel chemical scaffold and potently inhibits class I histone deacetylases (HDACs). Largazole possesses highly differential growth-inhibitory activity, preferentially targeting transformed over non-transformed cells. The intriguing structure and biological activity of largazole have attracted strong interest from the synthetic chemistry community to establish synthetic routes to largazole and to investigate its potential as a cancer therapeutic. This Highlight surveys recent advances in this area with a focus on the discovery, synthesis, target identification, structure-activity relationships, HDAC8-largazole thiol crystal structure, and biological studies, including in vivo anticancer and osteogenic activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in cellular contexts, the IC50 values of thiol HDACi decrease significantly, due to reduction/hydrolysis of prodrugs. Whereas in vitro experiments that lack reductants or hydrolases show increased IC50 values of such inhibitors [85, 86].”
From Medicinal chemistry advances in targeting class I histone deacetylases (2023) · cites this paper as [86]
In the citing paper
“Similarly, largazole (Figure 15A), a thioester, is recognized as a thioesterase substrate in cells and is hydrolyzed to release a free thiol as a ZBG (Figure 15B) [86, 87].”
From Medicinal chemistry advances in targeting class I histone deacetylases (2023) · cites this paper as [86]
In the citing paper
“Cyanobacteria are known to be a rich source of highly bioactive natural products32–35, and in particular, protease inhibitors from numerous chemical classes36–41.”
From Native metabolomics identifies the rivulariapeptolide family of protease inhibitors (2022) · cites this paper as [32]
Citations
Cites
(2002) · PubMed · Cited by 732
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004) · The Prostate · doi:10.1002/pros.20022 · Cited by 509
Marine Natural Products: A New Wave of Drugs?
Montaser, R., & Luesch, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.118 · Cited by 437
Self-citationTaori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428
Self-citationRole of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Agathanggelou, A., Cooper, W. N., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4088 · Cited by 388
Luesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010049y · Cited by 378
Self-citationBiologically active secondary metabolites from marine cyanobacteria
Nunnery, J. K., Mevers, E., & Gerwick, W. H. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.019 · Cited by 265
PTEN Level in Tumor Suppression: How Much Is Too Little?
Carracedo, A., Alimonti, A., & Pandolfi, P. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2488 · Cited by 246
Kawai, H., Li, H., Avraham, S., Jiang, S., & Avraham, H. K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11403 · Cited by 226
Total Synthesis and Molecular Target of Largazole, a Histone Deacetylase Inhibitor
Ying, Y., Taori, K., Kim, H., Hong, J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8013727 · Cited by 222
Self-citation
Research works printed but not linked: 6
- Behar, 2010, Newsweek, 156, 40
- Furumai, 2002, Cancer Res., 62, 4916
- Ren, 2008, Synlett, 2379
- Numajiri, 2008, Synlett, 2483
- Wang, 2009, Synthesis, 2873
- Jeon, 2010, Int. J. Oncol., 37, 419
Cited by
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Ho, T. C. S., Chan, A. H. Y., & Ganesan, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00830 · Cited by 795
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2014) · Natural Product Reports · doi:10.1039/c3np70117d · Cited by 484
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
Bioactive thiazole and benzothiazole derivatives
Rouf, A., & Tanyeli, C. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.058 · Cited by 375
Branching Out: Rhodium-Catalyzed Allylation with Alkynes and Allenes
Koschker, P., & Breit, B. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00252 · Cited by 359
Metadata
- Authors
- Hong, J., & Luesch, H.
- Affiliations
- Duke University (US)
- University of Florida (US)
- Corresponding author
- Hong, Jiyong
- Luesch, Hendrik
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 29
- Issue
- 4
- Pages
- 449
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- PMC
- PMC4777309
- OpenAlex
- W2089288742
- Cited by
- 174
- References
- 47
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 7 · 2023: 14 · 2022: 16 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 14 · 2017: 6 · 2016: 8 · 2015: 11 · 2014: 20 · 2013: 12 · 2012: 6
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Natural Product Reports (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA138544)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- largazole, Symploca, cyclic depsipeptides, marine natural products, HDAC8, anticancer activity, osteogenic differentiation, structure-activity relationship, total synthesis, crystal structure, cancer therapy
- MeSH terms
- Cyanobacteria, Antineoplastic Agents, Biological Products, Humans, Marine Biology, Structure-Activity Relationship, Thiazoles, Molecular Structure, Depsipeptides, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Largazole: From discovery to broad-spectrum therapy. https://app.cochat.ai/papers/10.1039/c2np00066k
- The paper
- Hong, J., & Luesch, H. (2012). Largazole: From discovery to broad-spectrum therapy. Natural Product Reports. https://doi.org/10.1039/c2np00066k
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.